All News
Ozempic for Alzheimer's? What Drives Brain Age; Primary Care Alzheimer's Guideline
(MedPage Today) -- Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in 2025.
Read MoreImcivree Label Expanded; Weight Loss With Weekly Injection; Kidney Donation Chain
(MedPage Today) -- The FDA expanded the indication for setmelanotide (Imcivree) to include children as young as 2 years with syndromic or monogenic obesity due to Bardet-Biedl syndrome or genetically
Read MoreHigher-Dose Anticoagulation Not a Sure Bet for Hospitalized COVID Patients
(MedPage Today) -- Trials evaluating anticoagulation in patients hospitalized for COVID-19 did not consistently favor stepping up dosing for short-term survival, according to a systematic review and
Read MoreVaccine Injury Claims Spiked During COVID
(MedPage Today) -- The federal Countermeasures Injury Compensation Program (CICP) fielded a massive influx of claims due to the COVID-19 pandemic, according to a report from the U.S.
Read MoreBill Clinton Hospitalized; Lower Cost Ozempic? WHO Withdrawal Planned
(MedPage Today) -- Note that some links may require registration or subscription. Former President Bill Clinton was admitted to MedStar Georgetown University Hospital in Washington, D.C.
Read MoreDoc Indicted in Old Rape Case; Telehealth Death Suit; $66M Plastic Surgery Award
(MedPage Today) -- Ohio doctor Frederick Tanzer, MD, has been indicted on federal charges related to a rape case from 1989.
Read MoreLGBTQ+ People Relive Old Traumas as They Age on Their Own
The generation that faced discrimination, ostracism, and the AIDS epidemic now faces old age. Many struggle with isolation along with a host of pressing health problems.
Read MoreMel Robbins and ‘The Let Them Theory’
The self-help phenom’s new book is all about letting others do as they may.
Read MoreHow retractions get weaponized on social media
Retractions are meant to maintain trust in science — but on social media, they're often used to reinforce anti-science bias
Read MoreSTAT+: 3 trends to watch in telehealth in 2025
After multiple short-term extensions, telehealth providers are eager for Congress to lay out its long-term plans for the sector.
Read More